StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report sent to investors on Saturday. The firm issued a sell rating on the stock. Oncternal Therapeutics Stock Down 7.2 % Shares of Oncternal Therapeutics stock opened at $0.29 on Friday. The firm has a market cap of $17.37 million, […]
StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Wednesday morning. The firm issued a sell rating on the stock. ONCT has been the topic of several other research reports. Cantor Fitzgerald downgraded shares of Oncternal Therapeutics from an overweight rating to a neutral rating in […]
StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Tuesday. The firm issued a sell rating on the stock. Other research analysts have also issued research reports about the stock. Brookline Capital Management lowered shares of Oncternal Therapeutics from a buy rating to a hold rating […]
StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note issued to investors on Monday. The firm issued a sell rating on the stock. Other equities research analysts also recently issued reports about the stock. Brookline Capital Acquisition restated a hold rating on shares of Oncternal Therapeutics in a […]
StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research report report published on Monday morning. The firm issued a sell rating on the stock. Other equities research analysts have also recently issued reports about the stock. HC Wainwright cut shares of Oncternal Therapeutics from a buy rating to a […]